Evidence map›Paper›PMID 42006370›Full record

ArticleiScience2026

Frequency-specific electromagnetic modulation of brain redox state precedes cortical activity in stroke recovery.

Henry Hing Cheong Lee, Shira Reznik Balter, Nathaniel W Hodgson, Batsheva Weisinger, Esther Shohami, Glen M Doniger, Ana Parabucki, Yaron Segal, Takao K Hensch

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Henry Hing Cheong LeeFM Kirby Neurobiology Center, Department of Neurology, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA.
Shira Reznik BalterBrainQ Technologies Ltd., Givat Ram Hi-Tech Village, Booth 3.7, Jerusalem, Israel.
Nathaniel W HodgsonFM Kirby Neurobiology Center, Department of Neurology, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA.
Batsheva WeisingerBrainQ Technologies Ltd., Givat Ram Hi-Tech Village, Booth 3.7, Jerusalem, Israel.
Esther ShohamiBrainQ Technologies Ltd., Givat Ram Hi-Tech Village, Booth 3.7, Jerusalem, Israel.
Glen M DonigerBrainQ Technologies Ltd., Givat Ram Hi-Tech Village, Booth 3.7, Jerusalem, Israel.
Ana ParabuckiBrainQ Technologies Ltd., Givat Ram Hi-Tech Village, Booth 3.7, Jerusalem, Israel.
Yaron SegalBrainQ Technologies Ltd., Givat Ram Hi-Tech Village, Booth 3.7, Jerusalem, Israel.
Takao K HenschFM Kirby Neurobiology Center, Department of Neurology, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitigating oxidative stress is essential for recovery from stroke and other brain pathologies. Transient modulation of reactive oxygen species production triggers both cellular defense/repair mechanisms and neuroplasticity. Extremely low-frequency, low-intensity electromagnetic field (ELF-EMF) exposure may achieve both non-invasively. Here, we explored longitudinal consequences of frequency-specific ELF-EMF treatment on oxidative stress and cortical electrical activity in mice, and the implications for stroke recovery in humans. In mice, chronic (4w), daily 40Hz ELF-EMF (3h) exposure was neuroprotective across brain regions, as reflected in glutathione oxidation state. Notably, this followed an initial redox burden at treatment onset that was also detectable peripherally (urinary isoprostane, IsoP). Cortical rhythms emerged only gradually after chronic treatment. Enhanced EEG beta (13-30 Hz) power correlated with initial IsoP levels in mice and the degree of stroke recovery in humans. Taken together, ELF-EMF induces a sequential redox state dynamic that drives cortical activity toward functional recovery.

Indexed as

applied sciencesBiotechnologyEngineering

Identifiers

PMID42006370
PMCPMC13091406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.